Atropos Health is a real-world evidence and healthcare technology company founded in 2020 and headquartered in Palo Alto, California. The company combines technology, data, and physician-centered services to deliver data-driven medicine for individual patients.
Subscribe to see ATROPOS HEALTH INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ATROPOS HEALTH INC is a healthcare ai company headquartered in United States. It has raised at least $44.3M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $33M in May 2024. Xcout tracks 12 named people at ATROPOS HEALTH INC, including Neil Sanghavi (President, Products & Solutions).
6 more named people on record for ATROPOS HEALTH INC, with roles, board committees and tenure — see the full roster →
At least $44.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $33M | 7 named | |
| SEC Form D filing | $3.3M | — | |
| SEC Form D filing | $8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ATROPOS HEALTH INC's closest competitors — see the full list of competitors and alternatives →
Huma.AI, Inc. is a technology company headquartered in Palo Alto, California, that positions itself at the intersection of artificial intelligence and practical value for Medical Affairs.
OutcomesAI provides a clinical opportunity intelligence platform for healthcare organizations that extracts and structures patient data from electronic health records. The platform evaluates this evidence against physician-defined criteria to identify treatment opportunities and integrate them into clinical workflows.
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Higia, Inc. provides artificial intelligence solutions for population health management and chronic disease prediction. The company's platform analyzes patient data to identify individual risk factors, enabling healthcare professionals and patients to implement early interventions and preventive treatments.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.